Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HeezOn Ultra-1 is a botanical supplement formulation developed by Enovate Biolife for the treatment of male sexual dysfunction, specifically erectile dysfunction (ED) and premature ejaculation (PE). The product is an enhanced version of the company's existing HeezOn® supplement, incorporating a proprietary blend of botanical ingredients including Shilajit, Galangal, and Fenugreek. It is administered orally as two capsules daily, typically taken half an hour before dinner for a duration of 21 days. HeezOn Ultra-1 has been evaluated in randomized, double-blind, placebo-controlled clinical trials to assess its efficacy and safety in men with mild to moderate sexual dysfunction. As a natural product, it is categorized as a botanical or herbal formulation rather than a synthetic pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on HeezOn Ultra-1.